Uncategorized Archives - Page 55 of 251

MondayDec 27, 2021 12:01 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces White-Label Manufacturing Agreement With Averi Health Products

BevCanna Enterprises is a diversified health & wellness beverage company which specializes in providing white-label production and distribution solutions to its various partners The company recently entered into a manufacturing and distribution agreement with Averi Health Products, which will see BevCanna market Averi’s diverse range of non-alcoholic, cannabis-infused cocktails BevCanna has recently announced tie-ups with Keef Brands as well as with The Tinley Beverage Company to produce and distribute its products within the Canadian territory BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline,…

WednesdayDec 22, 2021 12:07 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Major Discovery; Increasing the Effectiveness of Orally Administered CBD

In a recent human clinical trial, HYPER-H21-2, DehydraTECH™-CBD reduced arterial stiffness, potentially broadening Lexaria's application's ability to treat cardiovascular and other diseases beyond hypertension Lexaria’s patented technology DehydraTECH improves how APIs enter the bloodstream –making multiple benefits possible such as increased delivery speed, increase in brain absorbency, higher bioavailability, and lower costs The company has patent protection received for delivery of nicotine, vitamins, NSAIDs, terpenes and cannabinoids; and patents pending for delivery of estrogen, testosterone, PDE5 inhibitors, antiviral drugs and more Oral absorption is the most convenient and widely used administration route for taking medications. Decades of research have advanced…

TuesdayDec 21, 2021 12:07 pm

As Cannabis Market Continues to Expand, Marijuana Company of America Inc. (MCOA) Anticipates Sustained Growth Following Record-Breaking Quarter

Education and job opportunities are being created for the sector, as more states and more countries around the word are pushing for cannabis legalization MCOA offers diverse operations that include both wholly-owned subsidiaries and investment interests, including Cannabis Global Inc., Eco Innovation Group Inc., and Natural Plant Extract During Q3 2021, the company saw its highest revenue earning quarter since it became public Despite challenges posed by the global pandemic, the legalized cannabis market is expected to grow significantly in the next five years. The market was valued at approximately $19.96 billion in 2018, and it is expected to grow…

TuesdayDec 21, 2021 10:39 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Natural Alkaline Spring Water Named as the Official Water Supplier for Vancouver’s 2022 Canadian E-Prix Event

BevCanna Enterprises’ TRACE line of natural alkaline and mineral-infused spring waters have been named as the official water supplier for Vancouver’s 2022 Canadian E-Prix event TRACE Natural Alkaline Spring Water, which originates from BevCanna’s wholly owned natural spring water aquifer in British Columbia, are renowned for their optimal mineral content and eco-friendly packaging BevCanna will launch a unique, commemorative package for its signature water brand in the run-up to the Vancouver E-Prix The event will serve to further propagate the TRACE brand name, with the company already named as the official water supplier to British Columbia’s firefighters BevCanna Enterprises (CSE:…

MondayDec 20, 2021 12:19 pm

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://cnw.fm/DNIbC). Data from…

FridayDec 17, 2021 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Reduces Arterial Stiffness in Study HYPER-H21-2 Broadening Applications Beyond Hypertension

Cardiovascular diseases are the leading cause of death worldwide and arterial stiffness serves as a significant marker of related conditions, including hypertension (high blood pressure) The company’s studies earlier this year indicated the potential of DehydraTECH to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation Arterial stiffness is a noted indicator of diseases such as heart, kidney and pancreas organ ailments that increase mortality with age, therefore the ability to reduce arterial stiffness may have implications for improving human wellness and longevity HYPER-H21-2 results evidence…

ThursdayDec 16, 2021 11:46 am

Marijuana Company of America Inc. (MCOA) Achieving Growth Through Acquisitions and Strategic Partnerships

MCOA just posted its highest quarterly revenue yet in Q3 2021, attributed to the cDistro acquisition, which was completed towards the end of Q2 2021 MCOA looks forward to having another record-breaking quarter in Q4, 2021, primarily attributed to additional benefits of the cDistro acquisition, along with strategic partnerships with key players within the legal cannabis and industrial hemp sectors The company continues to forge these partnerships to diversify its product and services line and provide consistent value to its shareholders Marijuana Company of America (OTC: MCOA) released financial results for the three months ended September 30, 2021 (“Q3 2021”),…

ThursdayDec 16, 2021 10:51 am

Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Introduces New Dry Herb Consumer Products; Issues 2022 Revenue Guidance of $35-45 Million

Flora Growth’s subsidiary, Vessel Brand, recently introduced new products for dry herb consumption and anticipates releasing additional products in 2022 FLGC acquired Vessel in a transaction that closed in November Founded in 2018, Vessel is an industry leader in the cannabis consumer technology and accessories space Flora Growth also announced a 2022 revenue guidance of $35-45 million CEO Luis Merchan held a webinar on December 14 in which he highlighted the company’s 2021 operational performance, commented on the revenue guidance, and fielded questions Flora Growth (NASDAQ: FLGC), an internationally focused company committed to delivering the most compelling customer experiences in…

TuesdayDec 14, 2021 1:17 pm

NCIA Presents 7th Annual Cannabis Business Summit & Expo

Venue: San Francisco, CA Date: December 15 - 17, 2021 Founded in 2010, the National Cannabis Industry Association (“NCIA”) is the oldest, largest, and most effective trade association representing the legal cannabis business. It is committed to promoting the growth of a responsible, sustainable, and inclusive cannabis industry, and works towards a favorable social, economic, and regulatory environment throughout the United States. NCIA’s 7th Annual Cannabis Business Summit & Expo will be held at the Moscone Center in San Francisco, California, from December 15-17, 2021. Throughout the three-day event, cannabis industry leaders and advocates Troy Datcher, Calvin Johnson, Jr., Rachael…

TuesdayDec 14, 2021 1:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Participates in the Benzinga Global Small Cap Conference; Committed to Innovation and Improving Quality of Life

Lexaria presented at this year’s Benzinga Global Small Cap Conference held on December 8-9, 2021 The event came right after the company announced human clinical hypertension study HYPER-H21-4, its most ambitious one yet Lexaria plans to sublicense its patented DehydraTECH(TM) technology worldwide, allowing for more people to benefit from it Going into 2022, the company looks forward to reporting on results from its HYPER-H21-3 clinical study and receiving Independent Review Board (“IRB”) approval for its HYPER-H21-4 study Lexaria Bioscience (NASDAQ: LEXX) just participated in this year’s Benzinga Global Small Cap Conference. The two-day event was a showcase for small cap…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized